Find uplifting stories about heroes, innovations, and solutions
14631 results for "targeted treatment"
Scientists discovered a more precise way to fight Huntington's disease by targeting only the most toxic form of the disease protein. This breakthrough could make treatments more effective than current approaches that reduce all forms of the protein.
Scientists developed technology that traces hundreds of cancer mutations back to shared control switches, potentially simplifying treatment. The breakthrough could mean one therapy targeting multiple genetic causes instead of treating each mutation separately.
A revolutionary therapy originally designed to fight blood cancer is helping people with severe lupus and other autoimmune diseases achieve remission. Early results show the treatment can reprogram the immune system instead of just suppressing it.
A simple biomarker test is helping doctors identify which ovarian cancer patients can benefit from precision treatments that work like guided missiles against tumors. The breakthrough offers new hope especially for women whose cancer stopped responding to traditional chemotherapy.
A new radiation treatment for advanced prostate cancer is helping patients skip harsh chemotherapy while getting better results. Texas Oncology in Longview is now offering Pluvicto, which delivers radiation directly to cancer cells.
Millions living with a painful, scarring skin disease may soon have hope for the first treatment designed specifically for their condition. The FDA just granted breakthrough status to a new drug that could change lives for people with cutaneous lupus.
Scientists created the first detailed maps showing how genes control each other in Alzheimer's brains, uncovering hundreds of targets for future treatments. The AI system named SIGNET goes beyond linking genes to revealing which ones actually drive the disease.
Scientists have discovered how to boost immune cells by changing their metabolism, opening a promising new path to treat skin cancers that resist current therapies. Clinical trials are already testing these metabolic treatments alongside immunotherapy.
Doctors in Buffalo are reprogramming patients' immune cells to fight autoimmune diseases the same way they fight cancer. The one-time treatment could replace lifelong medications for millions living with lupus, MS, and rheumatoid arthritis.
Revolutionary targeted therapies are turning once-deadly thyroid cancers into manageable diseases, giving patients real hope where there was little before. New medical guidelines help doctors navigate these breakthrough treatments that can shrink tumors and reduce invasive surgeries.
The FDA approved 10 new molecularly targeted cancer therapies in just one year, offering hope to patients with breast, lung, ovarian, prostate, brain, and blood cancers. These precision treatments attack cancer cells while sparing healthy tissue, marking a significant shift in how doctors fight the disease.
A new targeted therapy for a rare form of lung cancer just earned priority review from the FDA, potentially offering hope to thousands of patients who currently have limited treatment options. The drug specifically targets HER2 mutations found in about 2-4% of lung cancer cases.
New targeted therapies and immunotherapies for lung cancer are now reaching over 60% of patients with advanced disease, a dramatic improvement in treatment access. Fifteen states have enacted laws requiring insurance coverage for biomarker testing that helps match patients to lifesaving treatments.
Men with spreading prostate cancer can now postpone harsh hormone therapy for over two years thanks to a targeted radiation treatment that leaves healthy tissue untouched. A quarter of patients showed no tumors after treatment.
A therapy that fights cancer is being adapted to treat lupus, MS, and other autoimmune diseases affecting nearly one in 10 Americans. Researchers at Roswell Park aim to replace lifelong medications with a single infusion.
Elise Boyse beat Hodgkin's lymphoma at 18, then channeled her experience into groundbreaking cancer research that just earned her one of America's most prestigious science scholarships. The Davidson College junior is now using chemistry to develop gentler, more effective treatments for future patients.
Children with a rare brain cancer now have a new treatment option after European regulators approved Ojemda, a targeted therapy that works once a week. In trials, more than half of young patients saw their tumors shrink.
Scientists created a "smart" nanoparticle that targets ovarian cancer cells while leaving healthy tissue untouched. The breakthrough could make treatment safer and more effective for thousands of women.
A newly approved ALS treatment can now target specific genetic causes of the disease, offering hope to patients with Lou Gehrig's disease. The FDA fast-tracked the therapy, marking a significant breakthrough in personalized medicine for neurological conditions.
Researchers have identified 36 genes that significantly increase the risk for OCD and chronic tic disorders, opening the door to dozens of new treatment possibilities. The breakthrough could lead to therapies that target the root causes rather than just managing symptoms.
Showing 20 of 14631